Invoice Processing at Enterprise Speed: Transforming Accounts Payable Performance With strong expertise across industries, AROBS enables finance leaders to turn Accounts Payable from an administrative
Supercharge Stakeholder Communication In Finance with AI Automation Stakeholder communication mishaps slow down companies and expose them to a plethora of risks: regulatory, financial, and
From Vision to MedTech MVP in 6 Weeks: The HPO TECH Success Story Bringing a complex medical software product from idea to MVP in a
AROBS continues its growth strategy through the acquisition of Gess Engineering, an engineering company from Sibiu specialized in automotive system testing and validation Cluj-Napoca, November
AI-Powered Order Management For U.S. e-commerce and distribution companies, AI has rapidly shifted from experimental to essential. CapitalOne Shopping Research shows that nearly four in
Luxury Travel, Supercharged: scaling Personalization with AI The global luxury travel market is currently worth an estimated US $1.48 trillion and is projected to rise
AI-Powered Log Analytics for Medical Pumps: Harnessing LLMs for safer operations and compliance AI-powered solutions reshape the medical devices market today. With the global LLM
Predicting Power, Protecting Patients: AI-Driven Battery Intelligence for Medical Devices In Healthcare, a dead battery isn’t just an inconvenience – it’s a clinical threat. From
Zero Risks with AI-Powered Document Intelligence Solution When a large tech company was losing time and money chasing contracts across SharePoint, AROBS produced a game-changer:
AI-Driven Precision in Syringe Filling for Pharma and Laboratory Applications According to Data Bridge Market Research, the global medical automation market is valued at
Transformation of a 20+ years old legacy system for clinical trials ethics approvals A globally recognized pharmaceutical company was struggling with a legacy system, over
Umgestaltung eines über 20 Jahre alten Altsystems für die ethische Genehmigung klinischer Studien Ein weltweit anerkanntes Pharmaunternehmen kämpfte mit einem über 20 Jahre alten Legacy-System